Literature DB >> 14685170

Met, metastasis, motility and more.

Carmen Birchmeier1, Walter Birchmeier, Ermanno Gherardi, George F Vande Woude.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 14685170     DOI： 10.1038/nrm1261

Source DB:  PubMed          Journal:  Nat Rev Mol Cell Biol        ISSN： 1471-0072            Impact factor:   94.444


× No keyword cloud information.
  938 in total

1.  Mechanistic evaluation of the novel HSP90 inhibitor NVP-AUY922 in adult and pediatric glioblastoma.

Authors:  Nathalie Gaspar; Swee Y Sharp; Suzanne A Eccles; Sharon Gowan; Sergey Popov; Chris Jones; Andrew Pearson; Gilles Vassal; Paul Workman
Journal:  Mol Cancer Ther       Date:  2010-05       Impact factor: 6.261

2.  Expression and prognostic significance of CD151, c-Met, and integrin alpha3/alpha6 in pancreatic ductal adenocarcinoma.

Authors:  Guang-Hui Zhu; Chen Huang; Zheng-Jun Qiu; Jun Liu; Zhi-Hua Zhang; Ning Zhao; Zheng-Zhong Feng; Xiu-Hong Lv
Journal:  Dig Dis Sci       Date:  2010-10-07       Impact factor: 3.199

3.  HGF rescues colorectal cancer cells from EGFR inhibition via MET activation.

Authors:  David Liska; Chin-Tung Chen; Thomas Bachleitner-Hofmann; James G Christensen; Martin R Weiser
Journal:  Clin Cancer Res       Date:  2010-11-22       Impact factor: 12.531

4.  Early clinical development of ARQ 197, a selective, non-ATP-competitive inhibitor targeting MET tyrosine kinase for the treatment of advanced cancers.

Authors:  Alex A Adjei; Brian Schwartz; Edward Garmey
Journal:  Oncologist       Date:  2011-05-31

5.  Ezrin mediates both HGF/Met autocrine and non-autocrine signaling-induced metastasis in melanoma.

Authors:  Liping Huang; Yifei Qin; Qiang Zuo; Kavita Bhatnagar; Jingbo Xiong; Glenn Merlino; Yanlin Yu
Journal:  Int J Cancer       Date:  2017-12-15       Impact factor: 7.396

Review 6.  Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomains.

Authors:  Adriane Regina Todeschini; Sen-itiroh Hakomori
Journal:  Biochim Biophys Acta       Date:  2007-10-22

7.  Combined MET inhibition and topoisomerase I inhibition block cell growth of small cell lung cancer.

Authors:  Cleo E Rolle; Rajani Kanteti; Mosmi Surati; Suvobroto Nandi; Immanuel Dhanasingh; Soheil Yala; Maria Tretiakova; Qudsia Arif; Todd Hembrough; Toni M Brand; Deric L Wheeler; Aliya N Husain; Everett E Vokes; Ajit Bharti; Ravi Salgia
Journal:  Mol Cancer Ther       Date:  2013-12-10       Impact factor: 6.261

8.  Evidence for LKB1/AMP-activated protein kinase/ endothelial nitric oxide synthase cascade regulated by hepatocyte growth factor, S-adenosylmethionine, and nitric oxide in hepatocyte proliferation.

Authors:  Mercedes Vázquez-Chantada; Usue Ariz; Marta Varela-Rey; Nieves Embade; Nuria Martínez-Lopez; David Fernández-Ramos; Laura Gómez-Santos; Santiago Lamas; Shelly C Lu; M Luz Martínez-Chantar; José M Mato
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

9.  A human recombinant IL-7/HGFβ hybrid cytokine enhances antitumor immunity in mice.

Authors:  Feng Han; Rong Hu; Min Su; Yanni Yu; Hua Yang; Laijun Lai
Journal:  Am J Cancer Res       Date:  2017-08-01       Impact factor: 6.166

10.  NK4, an HGF antagonist, prevents hematogenous pulmonary metastasis by inhibiting adhesion of CT26 cells to endothelial cells.

Authors:  Takeshi Kubota; Hiroaki Taiyoh; Atsushi Matsumura; Yasutoshi Murayama; Daisuke Ichikawa; Kazuma Okamoto; Hitoshi Fujiwara; Hisashi Ikoma; Masayoshi Nakanishi; Shojiro Kikuchi; Chouhei Sakakura; Toshiya Ochiai; Yukihito Kokuba; Hiroki Taniguchi; Teruhisa Sonoyama; Kunio Matsumoto; Toshikazu Nakamura; Eigo Otsuji
Journal:  Clin Exp Metastasis       Date:  2009-02-21       Impact factor: 5.150
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.